Brasilinolide B
Latest Information Update: 15 Dec 2003
At a glance
- Originator Higeta Shoyu
- Class Antifungals
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Mycoses
Most Recent Events
- 15 Dec 2003 No development reported - Preclinical for Mycoses in Japan (unspecified route)
- 16 Feb 2000 Preclinical development for Mycoses in Japan (Unknown route)